midazolam has been researched along with letermovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Cho, CR; Hartmann, G; Menzel, K; Wang, YH | 1 |
| Erb-Zohar, K; Kropeit, D; McCormick, D; Rübsamen-Schaeff, H; Stobernack, HP; Zimmermann, H | 1 |
1 trial(s) available for midazolam and letermovir
| Article | Year |
|---|---|
Pharmacokinetics and Safety of Letermovir and Midazolam Coadministration in Healthy Subjects.
Topics: Acetates; Area Under Curve; Drug Interactions; Female; Healthy Volunteers; Humans; Midazolam; Quinazolines | 2022 |
1 other study(ies) available for midazolam and letermovir
| Article | Year |
|---|---|
PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling.
Topics: Acetates; Adult; Antiviral Agents; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytomegalovirus Infections; Drug Interactions; Drug Labeling; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypnotics and Sedatives; Liver-Specific Organic Anion Transporter 1; Male; Midazolam; Models, Biological; Quinazolines; Young Adult | 2019 |